Idorsia to Present at J.P. Morgan 2026 Healthcare Conference

Idorsia Ltd (SIX: IDIA) announced that Srishti Gupta, MD, the company’s Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 10:30 am PST / 7:30 pm CET in San Francisco, USA, held at the Westin St. Francis hotel. In her presentation, Dr. Gupta will discuss Idorsia’s recent operational progress and strategic priorities. She will highlight how the company, with two products entering a value‑acceleration phase and an innovative pipeline geared toward future breakthrough medicines, is navigating a path toward sustainable profitability and growth. Gupta emphasized Idorsia’s unique position as a commercial‑stage pharmaceutical company with blockbuster potential products and a highly innovative pipeline. She outlined plans to make QUVIVIQ the standard of care in insomnia, maximize the value of TRYVIO/JERAYGO for uncontrolled hypertension, and progress broader pipeline assets. The presentation will also address key operational achievements from 2025 and focus areas for 2026, including expanding global reach of existing products, initiating new clinical studies, and advancing pipeline candidates. A live audio webcast will be available, with a replay posted on Idorsia’s website after the event. #Idorsia #JPM2026 #HealthcareInnovation #BiopharmaGrowth #SlimScan #GrowthStocks #CANSLIM